These findings highlight the promise of GDF-15 as a valuable biomarker in the clinical assessment of bleeding risk, paving the way for more tailored and effective preventive strategies in this high-risk population.PerspectivesCOMPETENCY IN MEDICAL KNOWLEDGE: GDF-15 levels are associated with major bleeding risk but not VTE in patients with cancer. Here, GDF15 is linked to cancer.